Drug Store News8d
Biocon Pharma gets FDA nod for norepinephrine bitartrate injection
Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.
Medical News Today26d
Cymbalta side effects: What you should know
is a brand-name delayed-release oral capsule that the Food and Drug Administration (FDA) has approved to treat the following conditions in adults: Cymbalta belongs to the serotonin-norepinephrine ...
USA Today4d
FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
The U.S. Food and Drug Administration (FDA) has approved the first-ever testing kit for sexually transmitted infections that can be taken at home without a prescription. But it's not for everyone.
pharmaphorum1d
Axsome bounces back as FDA clears depression drug
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy ... rights to Jazz Pharma's dual-acting dopamine and norepinephrine reuptake inhibitor Sunosi (solriamfetol ...
Fierce Pharma7d
Axsome touts success of phase 3 trial of Sunosi in ADHD, adding to 'string of recent wins'
Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...
The Hill5d
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.
Biocon subsidiary secures FDA approval for critical blood pressure medication
Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...
IndiaInfoline8d
Biocon Pharma Gains USFDA Approval for Norepinephrine and Key Therapies
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.